Compare DLTH & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DLTH | QSI |
|---|---|---|
| Founded | 1989 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 154.7M | 165.6M |
| IPO Year | 2015 | 2020 |
| Metric | DLTH | QSI |
|---|---|---|
| Price | $4.37 | $1.48 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $5.00 | $2.28 |
| AVG Volume (30 Days) | 55.7K | ★ 10.9M |
| Earning Date | 12-15-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 64.12 | 28.17 |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $565,184,000.00 | $2,436,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.12 | $406.32 |
| P/E Ratio | $19.15 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.02 | $0.69 |
| 52 Week High | $5.09 | $2.19 |
| Indicator | DLTH | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 65.29 | 57.42 |
| Support Level | $3.82 | $0.81 |
| Resistance Level | $4.77 | $1.66 |
| Average True Range (ATR) | 0.15 | 0.16 |
| MACD | 0.05 | 0.02 |
| Stochastic Oscillator | 86.51 | 58.74 |
Duluth Holdings Inc is an apparel brand in the United States. The company offers shirts, pants, and casual wear for men and women under brands like Alaskan Hardgear, Armachillo, Ballroom, Cab Commander, Crouch Gusset, Dry on the Fly, Duluth Trading Co, Duluthflex, Fire Hose, Longtail T, No Polo Shirt, No Yank, Wild Boar, and others. The Company's revenue consists of the sale of apparel, footwear, and hard goods. The company operates in a single operating segment.
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.